Hjem › Multipelt myelom › California › Irvine
Kliniske studier for Multipelt myelom i Irvine, CA
14 studier for Multipelt myelom søker deltakere på steder i og rundt Irvine (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma
RekruttererFase 2
- City of Hope Orange County Lennar Foundation Cancer Center, Irvine
A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
RekruttererFase 1
- City of Hope - Orange County Lennar Foundation Cancer Center /ID# 279067, Irvine
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
RekruttererFase 1
- City of Hope Orange County Lennar Foundation Cancer Center, Irvine
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
RekruttererFase 1/2
- City of Hope Irvine Lennar, Irvine
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
RekruttererFase 3
- UC Irvine Health Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
RekruttererFase 3
- City of Hope Orange County Lennar Foundation Cancer Center, Irvine
Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study
RekruttererFase 2
- City of Hope at Irvine Lennar, Irvine
A Study of IBI3003 in Subjects With Relapsed or Refractory Multiple Myeloma
RekruttererFase 1/2
- City of Hope - Lennar, Irvine
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
RekruttererFase 3
- City of Hope Orange County Lennar Foundation Cancer Center, Irvine
Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma
RekruttererFase 3
- City of Hope - Lennar Foundation Cancer Center, Irvine
AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma
RekruttererFase 1/2
- Research Site, Irvine
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
RekruttererFase 1/2
- City of Hope - Orange County Lennar Foundation Cancer Center /ID# 277911, Irvine
Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)
RekruttererFase 4
- UCI Health - Irvine Infusion Pharmacy ACC, Irvine
A Multicenter Prospective Observational Cohort Study Evaluating the Impact of Cancer-Directed Treatment and Medication Use, Including Cannabis Use, in Multiple Myeloma Patients
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- City of Hope at Irvine Lennar, Irvine
Multipelt myelom-studier i andre byer
- New York City, NY60 studier
- Boston, MA42 studier
- Atlanta, GA41 studier
- Houston, TX38 studier
- Durham, NC37 studier
- Nashville, TN32 studier
- Denver, CO27 studier
- Rochester, MN24 studier
- St. Louis, MO24 studier
- Columbus, OH24 studier
- Baldwin Park, CA23 studier
- Chicago, IL22 studier
Andre studier i Irvine
- Ikke-småcellet lungekreft25 studier
- Brystkreft23 studier
- Kreft (alle typer)16 studier
- Metastatisk kreft16 studier
- Lungekreft15 studier
- Prostatakreft14 studier
- Eggstokkreft12 studier
- Alzheimers sykdom11 studier
- Plateepitelcancer i hode og hals11 studier
- Blærekreft11 studier
- Kolorektal kreft10 studier
- Pankreaskreft10 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.